ArticlePloS one2026
Association of NUDT17 rs9286836 and rs2004659 variants with breast cancer risk in Bangladeshi Women.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a multifaceted illness impacted by genetic factors as well as environmental influences. While variants in the NUDT17 gene have been associated with cancer biology, their involvement in breast cancer is still inadequately investigated, especially within South Asian populations. This study investigated the association between two NUDT17 polymorphisms, rs9286836 and rs2004659, and breast cancer risk in Bangladeshi women using a case-control design. A total of 240 breast cancer patients and 240 age-, sex-, and BMI-matched healthy controls were enrolled. Genomic DNA was extracted from blood samples, and genotyping was performed using tetra-primer ARMS-PCR for rs9286836 and PCR-RFLP for rs2004659. The statistical methods employed included chi-square tests for genotype distributions and logistic regression to calculate odds ratios (ORs) with 95% confidence intervals (CIs). Genotyping for NUDT17 rs9286836 was successfully completed for all recruited participants. However, for rs2004659, high-quality genotyping data were available for 204 breast cancer cases and 204 controls after quality control procedures. No significant association was observed between rs9286836 and breast cancer risk across the tested genetic models. In contrast, rs2004659 showed a robust protective association with breast cancer, particularly among heterozygous individuals, and this protective effect was consistently observed across the dominant, over-dominant, and allelic models. Haplotype analysis revealed that the AA haplotype was associated with an increased risk of breast cancer, whereas the AG and GA haplotypes were associated with a reduced risk. Expression analysis further demonstrated elevated NUDT17 levels in breast cancer tissues and genotype-dependent expression effects for both variants. These findings suggest a protective role of rs2004659 in breast cancer susceptibility and highlight the potential of NUDT17 polymorphisms as biomarkers in Bangladeshi women.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.